SEARCH

SEARCH BY CITATION

References

  • 1
    Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53:957978. MEDLINE
  • 2
    Matuschak GM, Rinaldo JE, Pinski MR, Gavaler JS, Van Thiel DH. Effect of end stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J Crit Care 1987; 2:162173.
  • 3
    Meldrum D, Mitchell MB, Banerjee A, Harken AH. Cardiac preconditioning. Induction of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 1993; 128:12081211. MEDLINE
  • 4
    Liang-Xiong FU, Kirkeboen KA, Liang QM, Sjorgren KG, Hjalmarson A, Hebekk A. Free radical scavenging enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium. Cardiovasc Res 1993; 27:612616. MEDLINE
  • 5
    Parrat JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Tips Reviews 1994; 15:1925.
  • 6
    Peralta C, Hotter G, Closa D, Gelpí E, Bulbena O, Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion: role of nitric oxide and adenosine. Hepatology 1997; 25:934937. MEDLINE
  • 7
    Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, Williams JW. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66:152157. MEDLINE
  • 8
    Colletti LM, Burtch GD, Remick DG, Kunkel SL, Strieter RM, Guice KS, Oldham KT, et al. Production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1989; 49:268273.
  • 9
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-α in the pathophysiologic alterations following hepatic ischemia/reperfusion in the rat. J Clin Invest 1990; 85:19361943. MEDLINE
  • 10
    Meldrum DR, Dinarello CA, Shames BD, Cleveland JC, Cain BS, Banerjee A, Meng X, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 1998; 98:214219.
  • 11
    Hotter G, Closa D, Prados M, Fernández-Cruz L, Prats N, Gelpí E, Roselló-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996; 222:2732. MEDLINE
  • 12
    Bilinska M, Maczewski M, Beresewicz A. Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart. Mol Cell Biochem 1996; 161:265271.
  • 13
    Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28:768773. MEDLINE
  • 14
    Eigler A, Sinha B, Endres S. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cell. Biochem Biophys Res Commun 1993; 196:494501. MEDLINE
  • 15
    Garcia Criado FJ, Eleno N, Santos Benito F, Valdunciel JJ, Reverte M, Lozano Sánchez FS, Ludeña MD, et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 1998; 66:982990. MEDLINE
  • 16
    Eigler A, Sinha B, Endres S. Nitric oxide–releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear. Biochem Biophys Res Commun 1993; 196:494501. MEDLINE
  • 17
    Klemm P, Warner TD, Hohlfeld T, Corder R, Vane JR. Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci U S A 1995; 92:26912695. MEDLINE
  • 18
    Scales WE, Campbell DA, Green ME, Remick DG. Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions. Am J Physiol 1994; 267:G1122G1127. MEDLINE
  • 19
    Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10:182191. MEDLINE
  • 20
    Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology 1998; 27:11721177. MEDLINE
  • 21
    Schmekel B, Karlsson SE, Linden M, Sundström C, Tegner H, Venge P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990; 14:447454. MEDLINE
  • 22
    Trush MA, Egner PA, Kensler TW. Myeloperoxidase as a biomarker of skin irritation and inflammation. Fed Chem Toxic 1994; 32:143147.
  • 23
    Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993; 21:S447S463. MEDLINE
  • 24
    Wake K, Decker K, Kirn A, Knook DL, McCuskey RS, Bouwens L, Wisse E. Cell biology and the kinetics of Kupffer cells in the liver. Int Rev Cytol 1989; 118:173229. MEDLINE
  • 25
    Guice KS, Oldham KT, Remick DG, Kunkel SL, Ward PA. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis J Surg Res 1991; 51:495499.
  • 26
    Noel AA, Hobson RW, Durán WN. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc Res 1996; 52:210220. MEDLINE
  • 27
    Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpí E, Roselló-Catafau J. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29:126132. MEDLINE
  • 28
    Stadler J, Harbrecht BG, Di Silvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 1993; 53:165172. MEDLINE
  • 29
    Peralta C, Closa D, Hotter G, Gelpí E, Prats N, Roselló-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996; 229:264270. MEDLINE
  • 30
    Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988; 33:664666.
  • 31
    Grieg PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor B, Blendis LM, et al. Treatment of primary liver graft non function with prostaglandin E1. Transplantation 1989; 48:447453. MEDLINE
  • 32
    Ringe B, Pinchlmayr R, Lübbe N, Bornscheuer A, Kuse E. Total hepatectomy as a temporary approach to acute hepatic or primary graft failure. Transplant Proc 1988; 20:552557. MEDLINE
  • 33
    Takei Y, Marzi I, Kauffman FC, Currin RT, Lemasters JJ, Thurman RG. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990; 50:1420. MEDLINE
  • 34
    Mor E, Klintmalm GB, Gonwa TA, Solomon H, Holman MJ, Gibbs JF, Watemberg I, et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53:383386. MEDLINE